Want to see IN:AKUMS full AI Analyst Report?

Akums Drugs and Pharmaceuticals Limited (AKUMS) Ratios

4 Followers

Akums Drugs and Pharmaceuticals Limited Ratios

IN:AKUMS's free cash flow for Q4 2024 was ₹0.33. For the 2024 fiscal year, IN:AKUMS's free cash flow was decreased by ₹ and operating cash flow was ₹0.07. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 25	Mar 24	Mar 23
Liquidity Ratios
Current Ratio	―	2.55	3.25	1.60	1.52
Quick Ratio	―	1.78	2.56	1.08	0.94
Cash Ratio	―	0.11	0.35	0.09	0.04
Solvency Ratio	―	0.47	0.19	0.04	0.08
Operating Cash Flow Ratio	―	0.52	1.11	0.41	0.14
Short-Term Operating Cash Flow Coverage	―	34.07	16.60	1.21	0.42
Net Current Asset Value	₹ ―	₹ 12.25B	₹ 14.44B	₹ -8.55B	₹ -6.19B
Leverage Ratios
Debt-to-Assets Ratio	―	0.02	0.03	0.16	0.19
Debt-to-Equity Ratio	―	0.03	0.05	0.80	0.86
Debt-to-Capital Ratio	―	0.03	0.05	0.44	0.46
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.10	0.14
Financial Leverage Ratio	―	1.35	1.64	4.96	4.55
Debt Service Coverage Ratio	―	11.97	3.02	0.38	0.55
Interest Coverage Ratio	―	10.22	3.91	7.16	4.16
Debt to Market Cap	―	<0.01	0.01	0.04	0.04
Interest Debt Per Share	―	7.93	16.43	42.71	42.25
Net Debt to EBITDA	―	-0.02	-0.36	3.48	1.84
Profitability Margins
Gross Profit Margin	―	39.43%	21.50%	35.76%	33.59%
EBIT Margin	―	9.23%	10.92%	0.12%	5.65%
EBITDA Margin	―	13.00%	14.47%	3.25%	8.89%
Operating Profit Margin	―	7.63%	8.43%	8.95%	5.51%
Pretax Profit Margin	―	8.48%	8.77%	-1.13%	4.33%
Net Profit Margin	―	8.31%	5.85%	-0.10%	2.73%
Continuous Operations Profit Margin	―	8.44%	5.88%	0.02%	2.82%
Net Income Per EBT	―	97.95%	66.79%	8.91%	63.11%
EBT Per EBIT	―	111.14%	103.98%	-12.58%	78.56%
Return on Assets (ROA)	―	8.22%	4.68%	-0.11%	2.90%
Return on Equity (ROE)	―	11.10%	7.70%	-0.57%	13.23%
Return on Capital Employed (ROCE)	―	9.65%	8.44%	15.61%	9.56%
Return on Invested Capital (ROIC)	―	9.55%	5.56%	-0.23%	5.12%
Return on Tangible Assets	―	8.24%	4.69%	-0.12%	2.91%
Earnings Yield	―	4.78%	3.58%	-0.04%	0.76%
Efficiency Ratios
Receivables Turnover	―	5.23	5.47	4.82	4.08
Payables Turnover	―	3.84	5.68	4.85	4.07
Inventory Turnover	―	3.62	4.53	4.10	3.16
Fixed Asset Turnover	―	2.60	2.68	2.89	2.87
Asset Turnover	―	0.99	0.80	1.14	1.06
Working Capital Turnover Ratio	―	3.86	2.27	5.79	5.44
Cash Conversion Cycle	―	75.40	83.08	89.61	115.27
Days of Sales Outstanding	―	69.76	66.70	75.71	89.55
Days of Inventory Outstanding	―	100.80	80.61	89.11	115.44
Days of Payables Outstanding	―	95.15	64.23	75.22	89.71
Operating Cycle	―	170.55	147.31	164.82	204.99
Cash Flow Ratios
Operating Cash Flow Per Share	―	31.09	79.09	34.58	11.22
Free Cash Flow Per Share	―	12.89	64.03	12.97	-9.67
CapEx Per Share	―	18.20	15.06	21.61	20.89
Free Cash Flow to Operating Cash Flow	―	0.41	0.81	0.38	-0.86
Dividend Paid and CapEx Coverage Ratio	―	1.71	5.25	1.60	0.54
Capital Expenditure Coverage Ratio	―	1.71	5.25	1.60	0.54
Operating Cash Flow Coverage Ratio	―	5.27	7.69	0.88	0.29
Operating Cash Flow to Sales Ratio	―	0.11	0.28	0.12	0.05
Free Cash Flow Yield	―	2.73%	13.74%	1.63%	-1.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	20.92	27.96	-2.84K	132.12
Price-to-Sales (P/S) Ratio	―	1.74	1.64	2.85	3.61
Price-to-Book (P/B) Ratio	―	2.32	2.15	16.17	17.47
Price-to-Free Cash Flow (P/FCF) Ratio	―	36.67	7.28	61.41	-82.36
Price-to-Operating Cash Flow Ratio	―	15.21	5.89	23.03	70.95
Price-to-Earnings Growth (PEG) Ratio	―	>-0.01	-1.07	27.18	-0.96
Price-to-Fair Value	―	2.32	2.15	16.17	17.47
Enterprise Value Multiple	―	13.34	10.95	91.33	42.38
Enterprise Value	―	70.61B	69.06B	119.29B	131.00B
EV to EBITDA	―	13.34	10.95	91.33	42.38
EV to Sales	―	1.73	1.58	2.97	3.77
EV to Free Cash Flow	―	36.61	7.05	63.84	-86.09
EV to Operating Cash Flow	―	15.18	5.70	23.94	74.17
Tangible Book Value Per Share	―	204.08	217.06	49.38	45.45
Shareholders’ Equity Per Share	―	203.66	216.44	49.23	45.57
Tax and Other Ratios
Effective Tax Rate	―	<0.01	0.33	1.02	0.35
Revenue Per Share	―	272.11	284.75	278.94	220.77
Net Income Per Share	―	22.60	16.67	-0.28	6.03
Tax Burden	―	0.98	0.67	0.09	0.63
Interest Burden	―	0.92	0.80	-9.10	0.77
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.03	0.13	0.01	0.01
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	1.35	4.74	-11.00	1.18

Currency in INR